Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Web site: http://www.acadia-pharm.com

Last updated March 5, 2008


Market Data powered by QuoteMedia. Terms of Use